Home › Obesity › Texas › Austin

Pag-aaral pangklinika para sa Obesity sa Austin, TX

Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2

Elligo Clinical Research Center /ID# 282166, Austin

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Nagre-recruitPhase 3

Texas Diabetes & Endocrinology, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Nagre-recruitPhase 3

Dell Children's Medical Center - PIN, Austin

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3

IMA Clinical Research Austin, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Nagre-recruitPhase 3

FutureSearch Trials of Neurology, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3

Austin Heart, Austin
Velocity Clinical Research - Austin, Austin

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2

IMA Clinical Research Austin, Austin

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

The University of Texas at Austin, Austin

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3

AURORA-1 Clinical Site, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3

AURORA-2 Clinical Site, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Nagre-recruitPhase 3

Austin Heart, Austin

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

ACCOMPLISH-2 Research Site, Austin

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Nagre-recruitPhase 2

IMA Clinical Research Austin, Austin

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Nagre-recruitPhase 3

Elligo Clinical Research Center, Austin

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3

Elligo Clinical Research Center, Austin

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Nagre-recruitPhase 3

Austin Heart, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Austin
ACCOMPLISH-1 Research Site, Austin

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Nagre-recruitPhase 1

Elligo Clin Res Centre, Austin

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Nagre-recruitPhase 1

Corxel Investigational Site, Austin

Edad 18 hanggang 55 · Kababaihan · Na-update Hun 17, 2026 · NCT07652047

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Dell Pediatric Research Center, Austin
University of Texas at Austin, Austin

Edad 30 hanggang 60 · Kababaihan · Na-update Hun 9, 2026 · NCT07480109

Pag-aaral para sa Obesity sa ibang lungsod

Iba pang pag-aaral sa Austin

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.